Fully Covered Metallic Stents for the Treatment of Benign Airway Stenosis
Autor: | Jean-Paul d'Odémont, Maximilien Gourdin, Caroline Dahlqvist, Sebahat Ocak, Laurie Putz, Anne-Sophie Dincq |
---|---|
Rok vydání: | 2016 |
Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Article Subject RC705-779 business.industry medicine.medical_treatment Stent medicine.disease Tracheal Stenosis Surgery Diseases of the respiratory system 03 medical and health sciences Stenosis Pneumonectomy 0302 clinical medicine 030228 respiratory system Self-expandable metallic stent Clinical Study medicine Intubation 030212 general & internal medicine Radiology Airway business Complication |
Zdroj: | Canadian Respiratory Journal, Vol 2016 (2016) Canadian Respiratory Journal |
ISSN: | 1916-7245 1198-2241 |
Popis: | Introduction.We herein report our experience with new fully covered self-expanding metallic stents in the setting of inoperable recurrent benign tracheobronchial stenosis.Methods.Between May 2010 and July 2014, 21 Micro-Tech® FC-SEMS (Nanjing Co., Republic of Korea) were placed in our hospital in 16 patients for inoperable, recurrent (after dilatation), and symptomatic benign airway stenosis. Their medical files were retrospectively reviewed in December 2014, with focus on stent’s tolerance and durability data.Results.Twenty-one stents were inserted: 13 for posttransplant left main bronchus anastomotic stricture, seven for postintubation tracheal stenosis, and one for postlobectomy anastomotic stricture. Positioning was easy for all of them. Stents were in place for a mean duration of 282 days. The most common complications were granulation tissue development (35%), migration (30%), and sputum retention (15%). Fifty-five % of the stents (11/20) had to be removed because of various complications, without difficulty for all of them. None of the patients had life-threatening complications.Conclusion.Micro-Tech FC-SEMS were easy to position and to remove. While the rate of complications requiring stent removal was significant, no life-threatening complication occurred. Further studies are needed to better define their efficacy and safety in the treatment of benign airway disease. |
Databáze: | OpenAIRE |
Externí odkaz: |